TETANUS
Clinical trials for TETANUS explained in plain language.
Never miss a new study
Get alerted when new TETANUS trials appear
Sign up with your email to follow new studies for TETANUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Thousands monitored: is the whooping cough vaccine safe in real life?
⭐️ VACCINE ⭐️ CompletedThis completed study tracked over 10,000 people in Thailand who received the Boostagen® vaccine, which protects against tetanus, diphtheria, and whooping cough. Healthcare workers reported any side effects to see how safe the vaccine is in everyday use. The study also looked at p…
Matched conditions: TETANUS
Sponsor: BioNet-Asia Co., Ltd. • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 09:09 UTC
-
New combo vaccine shows promise in protecting infants from five serious diseases
⭐️ VACCINE ⭐️ CompletedThis study tested a new vaccine called BK1310 in 267 healthy infants to see if it protects against tetanus, diphtheria, pertussis, polio, and bacterial meningitis as well as existing vaccines. Infants received three doses, and researchers measured their immune responses. The goal…
Matched conditions: TETANUS
Phase: PHASE3 • Sponsor: Tanabe Pharma Corporation • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 08:08 UTC
-
Booster shot study aims to keep teens safe from whooping cough
⭐️ VACCINE ⭐️ CompletedThis study tested a booster dose of the DTaP vaccine (BK1301) in 446 adolescents aged 11-12 who had already received the standard childhood series. The goal was to confirm the vaccine boosts immunity against diphtheria, tetanus, and pertussis (whooping cough) safely. Results show…
Matched conditions: TETANUS
Phase: PHASE3 • Sponsor: Tanabe Pharma Corporation • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 08:08 UTC
-
New tetanus antibody could replace Blood-Derived treatments
Disease control CompletedThis completed Phase 1/2 trial tested a new lab-made antibody called SNA02-48 for treating tetanus in 255 Chinese adults. The study compared SNA02-48 to the standard treatment (human tetanus immunoglobulin) to see if it is safe and how well it works. The goal is to find a more re…
Matched conditions: TETANUS
Phase: PHASE1, PHASE2 • Sponsor: Sinovac Life Sciences Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New tetanus antibody drug shows promise in early trial
Disease control CompletedThis study tested an experimental drug called TNM002 in 240 healthy Chinese adults to see if it can protect against tetanus as well as the standard treatment. Participants received a single injection of TNM002 at different doses, the standard tetanus antibody, or a placebo. The m…
Matched conditions: TETANUS
Phase: PHASE2 • Sponsor: Zhuhai Trinomab Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 26, 2026 18:30 UTC
-
Study: common chemicals could weaken vaccine power
Knowledge-focused CompletedThis study looked at whether exposure to PFAS chemicals (found in some water supplies) can weaken the body's immune response to the tetanus and diphtheria booster vaccine. Twenty adults from a community with known PFAS exposure received the vaccine and had blood and saliva sample…
Matched conditions: TETANUS
Phase: PHASE4 • Sponsor: Rutgers, The State University of New Jersey • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC